Government Affairs
Refine Search
Pharmaceutical
New bipartisan legislation has been proposed by two US Representatives that would fund critical research on treatments and cures for diseases including Alzheimer’s, cancer, blindness, juvenile diabetes, and sickle-cell anemia amid research delays caused by the pandemic. 25 May 2021
Pharmaceutical
The Russian government will use the mechanism of interventions in the domestic pharmaceutical market to tighten control of drug prices, according to recent statements by some senior state officials and local media, reports The Pharma Letter’s local correspondent. 25 May 2021
Pharmaceutical
Even as Asia attracted a significant amount of cross-border investment, accounting for more than half of global Foreign Direct Investment (FDI), FDI equity inflows into India increased by 13%, with the country receiving more than $30 billion in the first half of the financial year ending March 2021. With the Indian government seeking FDI specifically from companies intending to diversify manufacturing operations away from China, the $30 billion swell incorporates a tidy amount in the pharmaceutical sector, reports The Pharma Letter’s India correspondent. 19 May 2021
Biotechnology
Advanced therapy manufacturers in the UK have come together to raise awareness of the potential of next generation therapies and to support their development. 18 May 2021
Biosimilars
Medicines for Europe, the trade group representing the generics and biosimilars industry in Europe, has welcomed an update to the 2020 industrial strategy published by the European Commission (EC). 18 May 2021
Pharmaceutical
The Hellenic Association of Pharmaceutical Companies (SFEE) participated for the 6th consecutive year, on May 10, 2021, in the Delphi Economic Forum, held under the auspices of the President of the Hellenic Republic, M Katerina Sakellaropoulou. 17 May 2021
Pharmaceutical
The mere notion of the US government supporting any policies that might encourage pharmaceutical patents to be ignored would have seemed inconceivable only 18 months ago. 17 May 2021
Pharmaceutical
Staff from the US Federal Trade Commission, Canada’s Competition Bureau, the European Commission Directorate General for Competition, the UK’s Competition and Markets Authority, the U.S. Department of Justice’s Antitrust Division, and Offices of State Attorneys General has issued a notice seeking public comment to inform their review of how to best update their approaches to analyzing the effects of pharmaceutical mergers. 12 May 2021
Pharmaceutical
The Russian government will provide state subsidies for domestic drug exporters, in a move intended to raise the level of competitiveness of local drugs and their producers in the international arena, according to recent statements made by some senior state officials and local media reports. 10 May 2021
Biotechnology
Chugai Pharmaceutical has reached agreement with the Japanese government regarding the antibody cocktail casirivimab and imdevimab (formerly known as REGN-COV2), which is being investigated as a potential treatment for COVID-19. 10 May 2021
Pharmaceutical
Over the past weeks, vaccination is really starting to pick up the pace across the European Union. The numbers speak for themselves. Last week we saw more than 34 million doses delivered - a record in deliveries until now. By now we have passed the milestone of 200 million deliveries in the EU, commented European Commissioner Stella Kyriakides at a press conference yesterday. 7 May 2021
Pharmaceutical
To the surprise of many, the US government has backed a World Trade Organization (WTO) proposal to disclaim certain intellectual property (IP) rights to coronavirus vaccines, after previously opposing it. 6 May 2021
Pharmaceutical
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has filed its response to the European Union (EU) roadmap/IIA on the Evaluation and revision of the general pharmaceutical legislation. 30 April 2021
Generics
The Russian government plans to stimulate the production of active pharmaceutical ingredients (APIs) for the domestic sector, as part of a recent order by the country’s President, Vladimir Putin. 27 April 2021
Pharmaceutical
A cross-party group of members of parliament (MPs) and peers in the UK have signed a joint statement with patient advocacy organizations calling for Prime Minister Boris Johnson, ministers and senior civil servants to publish email, text and WhatsApp messages exchanged with pharma companies and their lobbyists. 26 April 2021
Biotechnology
US biotech Inovio Pharmaceuticals saw its shares crash nearly 25% to $6.85 by close of trading on Friday, after it revealed that the US government had pulled the plug on funding for its Phase III trial of COVID-19 vaccine candidate INO-4800. 26 April 2021
Generics
Serum Institute of India (SII) chief executive Adar Poonawalla has appealed to US President Joe Biden to lift the US embargo on exporting raw materials to help ramp up COVID-19 vaccine production. As the world grapples with vaccines short supply, Mr Poonawalla has flagged the US embargo on raw material exports. 19 April 2021
Biotechnology
Pfizer and BioNTech are to supply an additional 100 million doses of Comirnaty, the companies’ COVID-19 vaccine, to the 27 European Union (EU) member states in 2021. 19 April 2021
Pharmaceutical
Pharmaceutical associations uniting the largest foreign and Russian drug manufacturers and representatives of pharmacy chains, and the patient communities have asked Prime Minister Mikhail Mishustin to reject the initiative being developed by the Ministry of Industry and Trade, which in the professional community has been called "the second extra." 19 April 2021
Pharmaceutical
The government must support a patent waiver for COVID-19 vaccines and treatments to protect the UK’s own vaccination program, according to public health experts from the Independent SAGE group. 16 April 2021
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze